Alvotech ALVO
NASDAQ ALVO
$4.26 +0.27 (+6.77%)
As of: Aug 20, 2026 · 3:59 PM EDT

Alvotech (ALVO) Acquisitions (2022 - 2023)

Alvotech's (ALVO) quarterly Acquisitions came in at $11.2 million in Q4 2023, down 83.2% YoY from $66.4 million in Q4 2022, and down 83.2% on a QoQ basis from $66.4 million in Q4 2022.

Alvotech (ALVO) Acquisitions (2022 - 2023) Analysis & Trends

Alvotech (ALVO) has 2 years of Acquisitions data on file, last reported at $11.2 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Alvotech 1.26 Bn 1.26 Bn 5.09 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 11.16 Mn
Dec 31, 2022 66.43 Mn